Synapsins are neuronal proteins that bind and cluster synaptic vesicles in the presynaptic space, presumably by anchoring to actin filaments, but specific regulatory functions of the synapsins are unknown. We found that a sub-population of brain synapsin Ia, a splice variant of one of three synapsin isoforms, inhibits the GTPaseactivating protein (GAP) activity of several RGS proteins. Inhibition is highly selective for G␣ z , a member of the G i family that is found in neurons, platelets, adrenal chromaffin cells, and a few other neurosecretory cells. G z has been indirectly implicated in the regulation of secretion. Synapsin Ia constitutes a major fraction of the total GAP-inhibitory activity in brain, and its inhibitory activity is absent from the brains of synapsin I ؊/؊ / II ؊/؊ mice. Inhibition depends on the cationic D/E domain of synapsin. Phosphorylation of synapsin Ia at serine 9 by either cyclic AMP-dependent protein kinase or p21-activated protein kinase (PAK1) attenuates its potency as a GAP inhibitor more than 7-fold. Synapsin can thus act as a phosphorylation-modulated mediator of feedback regulation of G z signaling by the synaptic machinery.
G z is a member of the G i family of heterotrimeric G proteins that is expressed primarily in neurons, platelets, and adrenal chromaffin cells (1, 2) . Consistent with its expression in committed secretory cells, G z is apparently involved in signaling from cell surface receptors to the secretory machinery. It is required for normal platelet degranulation in response to ␣-adrenergic stimulation (3), contributes significantly to adrenocorticotropic hormone secretion in response to serotonin (4) , and the phenotype of Ga z knock-out mice suggests that it performs similar functions in multiple central nervous system neurons (5) . Although G z can regulate the usual group of G i effector proteins, it may also have unique targets of its own (2, 6, 7) .
G z is unusual in that it deactivates (hydrolyzes bound GTP) very slowly (t1 ⁄2 ϳ 5 min at physiological temperature) (8) . To carry out cellular signaling with reasonable response kinetics, G z relies on GTPase-activating proteins (GAPs) 1 of the RGS protein family. Members of the RGSZ subfamily can accelerate hydrolysis of G␣ z -bound GTP over 600-fold (9) , and other RGS proteins probably stimulate to similar extents (10) . Such acceleration both allows G z to respond to removal of receptor agonists on a reasonable physiological time scale and provides a way of inhibiting G z -mediated signaling by decreasing its activation lifetime (11) . Relatively little is known about how GAP activity is regulated in cells. RGS proteins can be inhibited by phosphorylation or palmitoylation, by binding to phosphatidylinositol 4,5-bisphosphate and by phosphorylation or palmitoylation of their G␣ substrates. However, the quantitative importance and physiological control of these processes are not well understood (see Refs. 11-13 for reviews).
During the purification of the G z -selective GAP RGSZ1 from brain, we noted that membrane-bound G z GAP activity increased when a crude cerebral cortical membrane fraction was washed with high ionic strength buffer (14) . We show here that the high salt extract contains protein inhibitors of G z GAP activity as well as inhibitors of other G protein GAPs. By purifying the inhibitory factors, we found that synapsin Ia is a major and selective inhibitor of G z GAP activity in brain.
Synapsins are abundant neuronal phosphoproteins that bind both actin filaments and synaptic vesicles, and they are responsible for ordered vesicle packing in the reserve pool of the synaptic terminal (see Refs. 15-17 for reviews). Three synapsin genes exist in mammals, and each is expressed as at least two splice products, but unique roles for the individual synapsin proteins have been hard to ascertain. Disruption of the genes for either or both major synapsin proteins I and II causes disorganization of synaptic vesicles and leads to a decrease in vesicle number. Consequent physiological effects of synapsin gene disruption include deficient vesicle recycling, altered adaptive response to paired or repetitive stimulation and a tendency to seizures (18 -21) . Long term and developmental anomalies caused by synapsin gene disruption may result from loss of synaptic vesicle organization but may also reflect novel regulatory roles of the synapsins (22) .
Diverse protein kinases phosphorylate synapsins at multiple sites in response to a wide variety of extracellular inputs (16) . Both CaM kinase II and p21-regulated kinase (PAK) catalyze phosphorylation of two serine residues, and phosphorylation at these sites results in the inability of synapsin to bind to actin (23) (24) (25) . One of these sites, serine 9, is also phosphorylated by cyclic AMP-dependent protein kinase (PKA) (23) . The complexity of synapsin phosphorylation suggests that it may mediate signaling events in addition to actin binding, and some of these events may account for yet unexplained effects of synapsin gene disruption. As an initial step toward understanding the functional interaction between synapsin I, G z , and RGS proteins in regulating synaptic activity, we characterize here the ability of synapsin Ia to inhibit G z GAPs and the control of inhibition by synapsin phosphorylation.
EXPERIMENTAL PROCEDURES
Materials-RGS proteins, G␣ i1 and G␣ o were expressed in Escherichia coli and purified as described previously (9, 10, 14) . Mixed synapsin isoforms were purified from bovine brain according to the method of Bä hler and Greengard (25) . Protein phosphatase 2A was a gift from Marc Mumby (University of Texas Southwestern). GST-PAK1(both fulllength and residues 232-544) (26) was a gift from Melanie Cobb (University of Texas Southwestern). The catalytic subunit of PKA was purchased from Sigma. G␣ z was purified from Sf9 cells as described previously (14) C-terminally His 6 -tagged rat synapsin Ia and a truncated form that contained only the A, B, and C domains (synABC; residues 2-419) were expressed in Sf9 cells using baculovirus vectors that were a gift from Johann Deisenhofer (University of Texas Southwestern) (27) . cDNAs that encode His 6 -tagged synABCD (residues 1-657) and synABCE (residues 419 -659 deleted) were prepared by polymerase chain reaction and transferred to baculovirus vectors as described (9) . Sf9 cell pellets were homogenized at 4°C in lysis buffer (25 mM Tris-Cl (pH 8), 1 mM 2-mercaptoethanol, 1 mM MgCl 2 , 0.02 mg/ml DNase I, and protease inhibitors (0.4 mM phenylmethylsulfonyl fluoride, 0.01 mg/ml leupeptin, 0.01 mg/ml aprotinin, 0.002 mg/ml pepstatin)). After 10 min, 250 mM NaCl and 1% Triton X-100 were added and the cell lysates were stirred for 30 min. After centrifugation (100,000 ϫ g, 30 min), the supernatant was diluted 4-fold with buffer A (20 mM NaHepes (pH 8), 10 mM 2-mercaptoethanol, 10% glycerol, and protease inhibitors) and applied to nickel-nitrilotriacetic acid-agarose that was equilibrated with buffer A plus 0.2% Triton X-100. The resin was washed with 200 ml of buffer A plus 1 M NaCl, 0.1% Triton X-100, and 7.5 mM imidazole and then with 50 ml of buffer A plus 100 mM NaCl, and 0.05% Triton X-100. Synapsin was eluted with buffer A plus 100 mM NaCl, 0.05% Triton X-100, and 150 mM imidazole. Purified synapsin was exchanged into storage buffer (50 mM NaHepes (pH 8), 0.05% Triton X-100, 5 mM dithiothreitol, 10% glycerol), flash-frozen in liquid nitrogen, and stored at Ϫ80°C. Protein was estimated according to the method of Schaffner and Weismann (28) throughout.
Purification of Bovine Synapsin Ia according to Inhibition of G z GAP Activity-All procedures were performed at 0 -4°C. Cerebral cortices from two to three steers were washed in 0.9% NaCl and homogenized in a Waring blender in 1 liter of TEP buffer (25 mM Tris-HCl (pH7.5), 1 mM MgCl 2 , 1 mM EDTA, 0.3 mM PMSF, 1 M pepstatin, 1 M leupeptin, 2 g/ml aprotinin). The homogenate was passed through cheesecloth and centrifuged at 30,000 ϫ g for 30 min. The pellet was homogenized in TEP buffer and centrifuged again. The pellet was suspended in 300 ml of TEP buffer plus 1 mM dithiothreitol and 300 mM NaCl, homogenized by five strokes with a Dounce homogenizer and stirred at 4°C for 30 min. The homogenate was centrifuged at 100,000 ϫ g for 45 min. The clear supernatant was diluted 6-fold with Buffer I (20 mM Hepes, pH 7.0, 1 mM EDTA, 1 mM dithiothreitol, 0.3 mM PMSF, 0.05% Lubrol PX) and passed through a 200-ml column of DEAE-Sephacel that was equilibrated with Buffer I. The flowthrough was incubated with 30 ml of CM-Sepharose 6B for at least 1 h. The resin was washed in a column with 200 ml of Buffer I and 50 ml of Buffer I plus 30 mM NaCl. Protein was eluted with a 150-ml gradient of 30 -300 mM NaCl in Buffer I. A broad peak of GAP-inhibitory activity was eluted between 150 and 250 mM NaCl. The pooled peak fractions (ϳ40 ml) were mixed with 4 M NaCl and 2 M (NH 4 ) 2 SO 4 to yield final concentrations of 1 M NaCl and 0.4 M (NH 4 ) 2 SO 4 . The mixture was centrifuged, and the supernatant was mixed with 5 ml of phenyl-Sepharose for 45 min. The resin was washed in a column with Buffer I plus 1 M NaCl and 0.4 M (NH 4 ) 2 SO 4 and GAP-inhibitory activity was eluted with buffer I. Pooled active fractions were diluted 5-fold with Buffer II (20 mM Hepes, pH 8.0, 1 mM EDTA, 1 mM dithiothreitol, 0.05% Lubrol, 0.3 mM PMSF) and applied to a column of Mono S (1.5 ml) that had been equilibrated with Buffer II. The column was washed sequentially with Buffer II, Buffer II plus 0.05 M NaCl, and a gradient of 0.05-0.40 M NaCl in Buffer II. Active fractions were concentrated on an Amicon PM10 membrane. Table II summarizes one such preparation.
GAP inhibitors were further purified by sequential SDS-polyacrylamide gel electrophoresis. Pooled inhibitor was denatured at room temperature in Tris-phosphate sample buffer (29) that contained 0.25% SDS and 10 mM dithiothreitol and fractionated by electrophoresis at 4°C on 10% acrylamide gels (ϳ0.2 mg on a 180-ϫ 150-ϫ 0.75-mm gel). Proteins were extracted from gel slices by homogenization in 5-10 volumes of renaturation buffer (20 mM NaHepes (pH 7.5), 1 mM dithiothreitol, 0.1 mM EDTA, 0.2% Triton X-100) and shaking overnight at 4°C. About 50 -60% of GAP-inhibitory activity was recovered from the gel. Activity was broadly distributed between 15 and 100 kDa (data not shown; recoveries in Table II) , with two peaks of activity reproducibly appearing at about 20 and 80 kDa. The 80-kDa region was cut and extracted again, and eluted protein was electrophoresed similarly on a 8% acrylamide gel. The highest inhibitory activity could be assigned to a single protein band with an apparent molecular mass of 75 kDa.
To compare GAP-inhibitory activity in brains of wild type and synapsin I Ϫ/Ϫ /II Ϫ/Ϫ mice (20) , inhibitor was partially purified by DEAESephacel and CM-Sepharose as described above. The active fractions were concentrated by Centricon PM10 and electrophoresed on 10% gels at 4°C. Activity was extracted from the 70-to 100-kDa and 15-to 25-kDa regions of the gels.
Protein Analysis-The ϳ75-kDa protein band from the 8% acrylamide gel described above was transferred electrophoretically to a polyvinylidene difluoride membrane and visualized by Amido Black staining. Protein bands were cut in 1-mm squares, and incubated for 18 h at 37°C in 15-20 l of 15 mM N-ethylmorpholine, 5 mM acetic acid, 1% Zwittergent 3-16 (Calbiochem) that contained 1 g of sequencing grademodified trypsin (Promega). The supernatant was collected, the membrane pieces were washed with another 15 l of digestion buffer, and both fractions were pooled for peptide analysis.
Electrophoresis and Immunoblotting-Samples were denatured, reduced with dithiothreitol, and alkylated by N-ethylmaleimide. Amounts of protein applied to gels for immunoblots were normalized according to Coomassie Blue staining of the specific band. Immunoblots from 8% acrylamide gels were probed with antiserum in 10% blocking solution and developed according to instructions in the ECL kit (Amersham Biosciences). Polyclonal synapsin antibody (E028), a gift from Thomas Sü dhof, was raised against a peptide common to all synapsin isoforms (30) . Anit-sera specific for individual phosphorylation sites in synapsin I (31) were a gift from Angus Nairn (Rockefeller University).
Immunodepletion of Synapsin-Synapsin (350 ng of purified brain fraction or 1 g of recombinant) was incubated with antibody (5 g of E028 or control) overnight at 4°C in 50 l of 20 mM Hepes (pH 7.5)/0.15 M NaCl/0.2% Lubrol. Protein A/G-agarose (Santa Cruz Biotechnology, ϳ20 g), equilibrated in the same buffer, was added, and the mixture was rotated at 4°C for 1 h. After centrifugation, 6 l of each supernatant was assayed for GAP inhibition. The amount of synapsin remaining in the supernatant was estimated by immunoblot.
GAP Assay-GAP activity was measured according to the acceleration of hydrolysis of [␥- 32 P]GTP that was pre-bound to a G␣ subunit as described previously (14, 32) . GAP activities are described either as the increment in the first-order rate constant for GTP hydrolysis (1 GAP unit ϭ 1 min Ϫ1 increment) or in terms of V max and K m for the overall reaction in which the GAP is formally assumed to catalyze the conversion of G␣-GTP to G␣-GDP. To quantitate inhibitory activity, we define a unit as the amount that decreases the G z GAP activity of RGS4 by 50%. For these assays, the concentration of RGS4 was 0.4 nM and that of G z -[␥-
32 P]GTP was usually ϳ2.5 nM (K m ϳ 8 nM). To measure inhibition of RGS4 with other G␣ substrates (see Table III Crude extracts of cerebral cortex were prepared by homogenizing cortex in 20 mM Hepes, 0.2% Triton X-100, 3 mM dithiothreitol, 1 mM EDTA, 0.2 mM PMSF, 5 g/ml pepstatin, 20 g/ml leupeptin, 20 g/ml aprotinin, and 300 mM NaCl, sonicating four times for 30 s and centrifuging at 30,000 ϫ g for 30 min to remove particulate material.
Synapsin Phosphorylation-To phosphorylate synapsin fractions, synapsin was incubated with or without 100 nM GST-PAK1 at 30°C for 2 h in 50 mM NaHepes (pH 8.0), 10 mM MgCl 2 , 1 mM dithiothreitol, and either unlabeled ATP or [␥-
32 P]ATP (0.5 mM). For phosphorylation with the catalytic subunit of PKA, the concentration of MgCl 2 was 5 mM and 0.1 mM EGTA was included. Reactions were terminated by addition of EDTA to 10 mM. Fractional phosphorylation was determined by scintillation counting of radioactive bands cut from polyacrylamide gels. For dephosphorylation with intestinal alkaline phosphatase or PP2A, either recombinant synapsin Ia (Rec) or synapsin Ia purified from brain (Nat) was treated as follows: 3.2 g of Rec or 1.6 g of Nat, 10 units of calf intestinal alkaline phosphatase (or phosphatase inactivated at 100°C for 10 min), 25 mM Tris-Cl (pH 8.4), 1 mM EDTA, 1 mM dithiothreitol, 10 g/ml leupeptin, 30 min, 30°C; 8 g of Rec or 2 g of Nat,
1.4 g of PP2A, 20 mM MOPS (pH 7.4), 20 g/ml bovine serum albumin, 1 mM dithiothreitol, 25 min, 30°C. For dephosphorylation with acid phosphatase, synapsin Ia (1 M recombinant or 0.5 M from bovine brain) was incubated at 30°C for 1.5-2 h with potato acid phosphatase (Sigma type VII; 0.3 unit/g of synapsin) in 25 mM MES-OH, pH 5.5, 2 mM MgCl 2 , 0.1 mM dithiothreitol, 10 g/ml leupeptin, 10 g/ml aprotinin, 0.3 mM PMSF, 2.5 mM benzamidine. In experiments where dephosphorylation followed in vitro phosphorylation reactions, hexokinase (1 unit) and 1 mM glucose were added to destroy ATP, and, after 20 min at 30°C, pH was adjusted to 5.0 -5.5 with MES before addition of acid phosphatase.
Synapsin Ia was hyperphosphorylated by exposing baculovirus-infected Sf9 cells to 1 M okadaic acid for 2 h before harvest. The lysis buffer included 25 mM Tris-Cl (pH 8.0), 1 mM 2-mercaptoethanol, 1 mM MgCl 2 , 20 g/ml DNase I, 50 mM NaF, 3 M p-nitrophenyl phosphate, 200 M sodium orthovanadate, 10 mM sodium pyrophosphate, 0.4 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 2 g/ml pepstatin, 250 mM NaCl, and 1% Triton X-100. Purification following lysis was as described above.
RESULTS

Identification of Synapsin Ia as a G z GAP Inhibitor in
Brain-In the course of purifying the G z -selective GAP RGSZ1 from bovine brain, we observed that total G z GAP activity in the membrane fraction increased about 2-fold after washing with high ionic strength buffer, which suggested that washing removed some inhibitory activity (14) . As shown in Table I , the high salt extract inhibited both the endogenous G z GAP activity of the washed brain membranes and the G z GAP activity of purified RGS4. The extent of inhibition increased with the amount of extract added to the GAP assay, and maximal inhibition exceeded 90% (Fig. 1A) . The extract could also inhibit the GAP activities of purified recombinant RGSZ1 or RGS10, although the extent and potency of inhibition varied depending on which GAP was used (see below). The inhibitory activity was sensitive to trypsin, was not found in cytosol, and was eluted from membranes maximally by 300 mM NaCl (data not shown). The inhibitor thus behaved like a cytoskeletal or peripheral membrane protein. GAP-inhibiting activity was found in several mammalian cell types, but was not found in Escherichia coli or in Sf9 insect cells (Fig. 1B) .
Because the GAP-inhibiting activity was most abundant in brain, we purified it from a high salt extract of bovine brain membranes. We used the inhibition of RGS4, a soluble and convenient nonspecific GAP (10) , to follow purification of inhibitory activity. As shown in Table II , inhibitory activity did not bind to anion exchangers but did bind to cation exchangers and to phenyl-Sepharose, and initial chromatographic purification was about 100-fold. However, the chromatographic behavior of the inhibitory activity suggested that it was not a single species. Partially purified inhibitor was permanently deactivated by heating in SDS plus dithiothreitol, but could be reactivated after exposure to SDS if it was not heated. This behavior allowed further separation of inhibitory factors by SDS-polyacrylamide gel electrophoresis followed by renaturation in buffer that contained Triton X-100. GAP-inhibiting activity was separated into two fractions of apparent molecular masses of 70 -80 and 15-20 kDa, neither of which was homogeneous according to protein staining. The two fractions contained about equal activity, and recovery of total activity was about 50% (Table II) . The low molecular weight fraction was diffuse according to both protein staining and activity (not shown) and was not studied further. The high molecular weight fraction contained discrete protein bands according to protein staining, and inhibitory activity could be assigned to a single protein band after electrophoresis on large gels under optimized conditions (Fig. 2) .
We purified larger amounts of the inhibitory species that electrophoresed with apparent M r of 75,000 by sequential gel electrophoresis as described in Fig. 2 . The appropriate protein bands, identified by Amido Black staining and activity assay, were excised and digested with trypsin. Tryptic peptides were identified by mass spectrometry and found to correspond to fragments of synapsin Ia. Coverage of the entire published sequence was 60% and included fragments from each of the domains A-E. Domain E distinguishes synapsin Ia from Ib, a product of alternative mRNA splicing (17) . Synapsin Ib was not detected, either because it was not active as an inhibitor or because its smaller size caused its inadvertent removal by electrophoresis. The electrophoretically purified inhibitor was also identified as synapsin by Western blotting (see Fig. 4 , insets). No fragments of other known proteins were detected, TABLE I GAP-inhibiting activity in bovine brain membranes G z GAP activity was measured in crude bovine brain membranes before and after washing with 1 M NaCl. The mixture of washed membranes plus high salt extract displayed a total activity of 31 milliunits, and the activity of the membranes after subtraction of the GAP activity in the extract is shown. The ability of the extract to inhibit the GAP activity of RGS4 is also shown, again after subtraction of the activity in the extract alone. Data are averages of duplicate determinations in two separate experiments and are expressed as milliunits of GAP activity (14, 32 Inhibition of G protein GAP activity by protein fractions from bovine cerebral cortex. A, the G z GAP activity of RGS4 was assayed in the presence of increasing concentrations of either a 30,000 ϫ g supernatant fraction (cytosol, OE), protein extracted from the crude membrane fraction with 1 M NaCl (ⅷ), or the NaCl extract after incubation for 15 min at 20°C with 10 g/ml of L-1-tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin (f). The extract was diluted to eliminate effects of NaCl on the assay. B, inhibition of the G z GAP activity of 0.4 nM RGS4 by 10 g of whole cell lysate protein from the cell types shown, or 10 g of a 300 mM NaCl extract of bovine brain membranes. Data shown have been corrected for the GAP activities contributed by the extracts themselves: platelets, 2.5 milliunits; 293 cells, 5.4 milliunits; Sf9 cells, 1.0 milliunit; E. coli, 0.5 milliunits; brain, 2.3 milliunits.
and only a few unidentifiable peptides were observed, all with low signals.
To confirm that the inhibitory activity purified from brain was indeed that of synapsin, rat synapsin Ia was expressed in Sf9 cells, purified to about 90% homogeneity and assayed for its effect in GAP assays. Recombinant synapsin Ia inhibited the G z GAP activity of RGS4 to the same maximal extent as did the electrophoretically purified synapsin Ia from bovine brain. The IC 50 for recombinant synapsin was ϳ15 nM, whereas that of the most active synapsin Ia fraction from brain was ϳ4 nM (Fig. 3) . Neither recombinant nor brain synapsin Ia altered the rate of hydrolysis of G␣ z -bound GTP in the absence of a GAP (not shown). The GAP-inhibitory activity of brain synapsin Ia could be depleted by immunoprecipitation with anti-synapsin antibodies (Fig. 4A) , and depletion paralleled removal of synapsin protein according to Western blot analysis of the supernatant. From the combined data of Figs. 2-4 , it is clear that pure synapsin I potently inhibits G z GAP activity.
To evaluate potential inhibitory activity of other synapsin isoforms, we also purified a mixture of synapsin protein from bovine brain by the method of Bä hler and Greengard (25) . This preparation was quite heterogeneous on SDS-polyacrylamide gels (data not shown), which results from the existence of three synapsin genes, alternative mRNA splicing (17), phosphorylation at multiple sites (16) , and O-linked glycosylation (33) . Total brain synapsin inhibited G z GAP activity, but maximal inhibition was less than 50% and potency was low (Fig. 3) . Inhibition of GAP activity may thus be a unique function of synapsin Ia and may reflect only a specific sub-population of this protein (see below).
To determine the contribution of synapsin to total brain GAP-inhibiting activity, we compared the inhibitory activity in brains of wild-type mice and mice whose synapsin I and II genes had been disrupted (20) . The GAP-inhibitory activity ascribed to synapsin Ia is predictably absent in brains of synapsin I/II knock-out mice. The 70-to 100-kDa fraction from the brains of the synapsin knock-out mice displayed Յ10% of the inhibitory activity of the same fraction from wild-type controls (Fig. 4B) . Western blots of these fractions confirmed that the brains from the knock-out mice did not contain immunoreactive synapsin (Fig. 4B) . As a positive control for the overall procedure, we found that the low molecular weight inhibitory fraction displayed comparable inhibitory activity in the fractions from the wild-type and knock-out mice (data not shown). Synapsin thus appears to be a major component of the inhibitory activity found in brain.
GAP Inhibition Depends Strongly on the Synapsin D Domain-Synapsins share three conserved N-terminal domains (A, B, and C). Relatively unconserved but generally basic Cterminal domains, D and E in synapsin Ia, are encoded by alternatively spliced exons and contribute to the observed heterogeneity of synapsin in brain (17) . Truncated versions of synapsin I that lack either the D or E domain, or both, were constructed to test their role in GAP inhibition. The E domain by itself is not required for inhibition of GAP activity, because (Table II) was resolved by electrophoresis in SDS on a 10% polyacrylamide gel as described under "Experimental Procedures." The activity peak in the 80-kDa region was identified by GAP inhibition assays after elution of protein from slices of the gel. This fraction was re-electrophoresed on a 180-ϫ 150-ϫ 0.75-mm 8% SDS-polyacrylamide gel. Eluates from 2-mm slices were eluted, and equal volumes of each fraction were analyzed either by a GAP inhibition assay after renaturation (upper panel) or by re-electrophoresis and Coomassie Blue staining (lower panel).
FIG. 3. Inhibition of RGS4 by synapsin fractions.
The G z GAP activity of RGS4 was assayed under standard conditions in the presence of increasing concentrations of electrophoretically purified inhibitor fraction from bovine brain (ⅷ), recombinant synapsin Ia purified from Sf9 cells (OE), or a preparation of mixed synapsin purified from bovine brain as described by Bä hler and Greengard (25) (f). Concentrations were calculated based on total protein and an assumed molecular weight of 74,000.
SynABCD inhibited fully and with a potency only slightly less than that of the full-length protein (IC 50 ϭ 20 nM versus 15 nM in the experiment shown in Fig. 5 ). In contrast, removal of the D domain to form SynABCE decreased inhibitory potency by about 75%, and SynABC was essentially inactive. The D domain of synapsin Ia is therefore essentially required for GAP inhibition. We also attempted to prepare SynD and SynDE to determine whether the D/E region of synapsin can independently inhibit GAP activity, but neither construct was expressed at a practical level, probably because of intracellular proteolysis.
Synapsin Ia Selectively Inhibits the G z GAP Activity of Multiple RGS Proteins-Synapsin inhibited GAP activity directed toward G␣ z but was minimally effective against G o and G i GAP activity (Table III) . Selectivity for G z is provocative, because both G z and synapsin are found primarily in neurons and other cells specialized for rapid secretion of signaling molecules. In parallel assays, we also tested whether brain membrane extracts contain other GAP inhibitors that are active with different G␣-GTP substrates. A crude detergent lysate of bovine cerebral cortex contained such inhibitory activity when measured with RGS4 and either G␣ o or G␣ i1 . We have not yet characterized or tried to purify the other inhibitory components.
In contrast to its selectivity for G z , synapsin inhibited the GAP activities of multiple RGS proteins. Of the three tested, RGS4 was the most sensitive to inhibition (Fig. 6) . RGSZ1, which is a selective G z GAP (9), was somewhat less sensitive to inhibition and displayed a biphasic inhibition curve. RGS10, which is a poor G z GAP with a high K m and probably a low V max (10) , displayed inhibition similar to that of RGSZ1. The lack of correlation between GAP activity and sensitivity to inhibition by synapsin was reinforced by comparison of wild-type RGS4 and a N-terminal truncation mutant from which the first 57 amino acid residues were removed to leave the RGS box and the short C-terminal extension (10) . Although this mutant was about 40-fold less active as a G z GAP, its sensitivity to inhibition by synapsin was similar to that of wild type (Fig. 6) .
To help clarify the mechanism of action of synapsin Ia, we analyzed its inhibition by standard enzymological criteria. GAP activity is best quantitated by considering the GAP as an enzyme that catalyzes the conversion of G␣-GTP to G␣-GDP, and GAPs display typical Michaelis-Menten kinetics in this context (32) . In these terms, synapsin inhibited the G z GAP activity of RGS4 by decreasing V max , with little if any effect on K m (Fig. 7) . This behavior is most simply explained by the   FIG. 4 . Identity of the 75-kDa inhibitor and synapsin. A, immunodepletion of inhibitory activity by anti-synapsin antibody. Samples of bovine synapsin purified according to its GAP-inhibiting activity and recombinant synapsin Ia were incubated with either anti-synapsin antibody or with a control antibody ("Cont"). Equal aliquots of the supernatants were then assayed for inhibition of GAP activity. Inset, aliquots of each supernatant after initial immunodepletion were analyzed by Western blotting with anti-synapsin antibody. B, inhibitor is absent in brains of synapsin I Ϫ/Ϫ , II Ϫ/Ϫ mice. The purification protocol developed for the GAP inhibitor in bovine brain was applied to membranes from brains of synapsin I Ϫ/Ϫ , II Ϫ/Ϫ (KO) or wild type mice (WT) (20) . The 70-to 90-kDa fraction from the first SDS-polyacrylamide gel was extracted, renatured, and assayed for inhibition of the G z GAP activity of RGS4. Each assay contained 0.5 g of protein.
Recombinant synapsin Ia (Sf9; 0.1 g) was also assayed for comparison. Inset, samples (same amounts as above) of each protein fraction were analyzed by electrophoresis and Western blotting using anti-synapsin antibody. binding of synapsin to RGS4 such that it inhibits G z GAP activity by 80% (Fig. 7, inset) without altering the affinity of RGS4 for its G␣ z -GTP substrate. Such a mechanism is plausible despite the selectivity of inhibition for G z if synapsin interferes with the RGS-G␣ z interaction that is needed to compensate for the unusual catalytic site of G␣ z , which hydrolyzes bound GTP about 3% as fast as do other members of the G i family (8) . Alternatively, synapsin may bind selectively to G␣ z rather than to RGS proteins and limit its susceptibility to GAP activity.
PAK1 and PKA Regulate GAP Inhibition by Phosphorylating Synapsin Ia at Ser
9 -Synapsin Ia purified from bovine brain was about 4-fold more potent a GAP inhibitor than is recombinant rat synapsin Ia (Fig. 3) . This difference was reproducible for multiple preparations of both proteins, and it is apparently intrinsic because both proteins were essentially pure. Because synapsin is phosphorylated at several sites in response to many stimuli (16), we treated both preparations with several specific and nonspecific protein phosphatases to test whether the difference in potency reflects differential phosphorylation. As shown in Fig. 8 , treatment with nonspecific acid phosphatase increased the potency of recombinant synapsin Ia about 2-fold and had only a small effect on the potency of bovine brain synapsin Ia. Intestinal alkaline phosphatase was less effective than potato acid phosphatase but also increased the inhibitory potency of both preparations (ϳ10%) (data not shown). These results, which were qualitatively reproduced in three independent experiments, suggest that recombinant synapsin Ia is phosphorylated in Sf9 cells and that phosphorylation makes it a less potent GAP inhibitor. In contrast to acid phosphatase, protein phosphatase 2A decreased the inhibitory potency of recombinant synapsin Ia by about 50% but had no effect on the activity of synapsin Ia from brain (data not shown). A fraction of recombinant synapsin Ia in Sf9 cells may also therefore be phosphorylated at a distinct serine/threonine residue where phosphorylation potentiates GAP-inhibitory activity. Because synapsin is phosphorylated at several sites by multiple kinases, such bi-directional regulation is not surprising.
To promote thorough phosphorylation of synapsin Ia, we incubated Sf9 cells with the protein phosphatase inhibitor okadaic acid and purified synapsin from these cells. Cellular hyperphosphorylation inhibited GAP regulation by synapsin Ia by about 75% compared with the control preparation and by 85% compared with control synapsin that had been treated with acid phosphatase (Fig. 9A) . Dephosphorylation more than reversed the effect of the okadaic acid by increasing potency about 6-fold. Phosphatase-treated synapsin from the cells exposed to okadaic acid was significantly more potent than untreated synapsin from control cells, although it was not as potent as phosphatase-treated control synapsin. Phosphorylation is thus capable of shifting the potency of synapsin over a 6-to 12-fold range. Preliminary mass spectrometric analysis indicated that the hyperphosphorylated synapsin was phosphorylated at 13 serine and threonine residues, although stoichiometry of phosphorylation has not been determined (data not shown). Multiple phosphorylation was also obvious from a large shift in electrophoretic mobility that was largely reversed by phosphatase treatment (Fig. 9A, inset) .
We used site-specific, phospho-specific antibodies to detect those sites at which recombinant synapsin Ia is phosphorylated in untreated Sf9 cells. Purified recombinant synapsin Ia was detectably phosphorylated at Ser 9 and somewhat less at Ser 549 (Fig. 9B) . (Phosphorylation of Ser 9 was also observed on the Western blot shown in Fig. 9C after prolonged exposure.) The protein kinases PAK, PKA, and CaM kinase II all phosphorylate Ser 9 in vivo in response to multiple regulatory inputs (23, 24) . The data of Fig. 9 (B and C) confirm that purified PKA and PAK1 phosphorylate Ser 9 on both recombinant synapsin Ia and Phosphorylation of Ser 9 by PAK or PKA inhibited regulation of G z GAP activity by synapsin Ia. PAK1-catalyzed phosphorylation decreased the potency of both recombinant synapsin Ia and brain synapsin Ia to approximately similar extents, 3-to 4-fold for each (Fig. 10A) . In these experiments, PAK1 phosphorylated synapsin Ia detectably only at Ser 9 (Fig. 9B) . Phosphorylation at Ser 603 , reported by Sakurada et al. (24) , was not detected. Phosphorylation by PKA inhibited the regulatory activity of synapsin by 76% and phosphorylation by PAK1 inhibited by 66% (Fig. 10B) . Because phosphorylation was only 75-80% efficient (Fig. 10B, see legend) , the phosphorylation of Ser 9 may inhibit the regulation of G z GAP activity by more than 90%. Inhibition by either PAK1 or PKA was reversed by treatment of synapsin with acid phosphatase, and the extent of reversal was similar to the extent of removal of phosphate from the synapsin (Fig. 10B) . Inhibition therefore reflects phosphorylation. Based on these data, phosphorylation of synapsin Ia at Ser 9 can significantly limit its ability to block G z GAP activity.
DISCUSSION
This study identifies synapsin I as a prominent, effective and potent G z GAP inhibitor in brain. Maximum inhibition can exceed 90%, and comparison of membranes before and after removal of synapsin suggest that synapsin Ia inhibits endogenous G z GAP activity by more than 25%. Because synapsin I is abundant and inhibition can be controlled by phosphorylation, it has the potential to modulate cellular G z GAP activity over a wide range. Synapsin Ia was the only synapsin purified as a GAP inhibitor, and it is likely to be the only significant GAP inhibitor among the synapsin proteins. Synapsin Ib was not found in the inhibitory fraction from bovine brain and was not a major component based on electrophoretic purification.
Synapsin Ia selectively inhibited the G z GAP activity of all RGS proteins tested and had little effect on GAP activity di- FIG. 9 . Cellular and in vitro phosphorylation of synapsin Ia. A, recombinant synapsin Ia was purified from Sf9 cells exposed to 1 M okadaic acid for 2 h before harvest (2 and 4) or from untreated cells (1 and 3) . Aliquots of each preparation were treated with acid phosphatase as described under "Experimental Procedures" (3 and 4) or incubated identically but without phosphatase (1 and 2) . Each sample was then assayed for inhibition of the G z GAP activity of RGS4. Data points are means from three experiments, each with duplicate determinations. The inset shows a silver-stained SDS-polyacrylamide gel of each sample. B, synapsin Ia was purified from okadaic acid-treated (Ok) or untreated Sf9 cells. A sample of synapsin from the untreated cells was also incubated with 100 nM GST-PAK1 for 2 h. Equal amounts of each sample were then electrophoresed in five separate sets. Four sets were immunoblotted with antibodies specific for the phosphoserine residues shown (31) , and the fifth was silverstained (Ag). C, synapsin Ia (0.5 M) from okadaic acid-treated or control cells was incubated with purified catalytic subunit of PKA (4 units/30 l). The two panels show a Western blot with anti-phosphoSer 9 antibody (WB) or silver-stained (Ag). Upon longer exposure, some phosphorylation of Ser 9 could be detected in the synapsin from the untreated cells (not shown).
rected toward other G␣ subunits (Table III) . Selectivity for a single G protein target would suggest that synapsin Ia binds G␣ z -GTP rather than RGS protein. However, synapsin Ia inhibits G z GAP by decreasing the k cat value, with no detectable effect on K m (Fig. 7) . Noncompetitive inhibition usually implies binding of inhibitor to the enzyme and is rarely contingent upon choice of substrate. In this case, it seems most likely that synapsin binds directly to G z in a synapsin-G z -RGS complex and render the G z insensitive to GAP activity. Demonstration of such a complex by microscopic co-localization of synapsin I with either G␣ z or a specific RGS protein in neurons is not feasible, because the concentration of total synapsin vastly exceeds that of either G␣ z or RGS proteins. We have also been unable to demonstrate direct in vitro binding of synapsin Ia to either G␣ z or an RGS protein using standard approaches over the concentration range in which inhibition is observed, however, so this issue is unresolved.
More broadly, this study describes the presence of multiple GAP inhibitory activities in tissues. GAP inhibitors other than synapsin with diverse specificities for different G␣-GTP substrates and RGS protein GAPs were found in brain but have not yet been identified (Table III) . GAP-inhibiting activity was found in brain, platelets, and several other mammalian cell types (Fig. 1) . The number of these inhibitors, their selectivities, and physiological regulation remain unknown but, presumably, vary among different cell types. Protein inhibitors add a new level of complexity to GAP action and may help determine the precise physiological functions of GAPs in cells. An additional practical conclusion is that G protein GAP activities measured in cell lysates may significantly underestimate the maximal activities of the RGS proteins in these fractions.
Phosphorylation-dependent Regulation of G z GAPs-The physiological linkage between G z and synapsin is intriguing. Both G z and the G z -selective RGS proteins are expressed in neurons and other neurosecretory cells (1, 2, 9, 34, 35) . The known function of synapsin is to tether synaptic vesicles to the actin cytoskeleton in such cells and to organize them in the reserve pool near the synaptic face (16, 17) . G z is apparently involved in signaling from receptor to the secretory machinery in platelets, hypothalamus, and elsewhere in the brain (3) (4) (5) . Although it has been hard to establish unique roles for G z in secretion distinct from those of the other members of the G i family, its patterns of receptor and effector coupling are increasingly recognized as distinctive (1, 2, 6, 36, 37) . G z or a G z GAP may be more directly involved in mediating secretion, as suggested by the partial intracellular localization of G␣ z (35) and by preliminary indications that RGSZ1 and RGSZ2, which are both G␣ z -selective GAPs, are enriched in synaptic vesicle fractions from rat brain. 2 Such localization is further suggested by the cysteine string in RGSZ family members, because palmitoylated cysteine strings tend to associate with secretory vesicles (Refs. 38 and 39 and references therein). The prototypical cysteine string protein is also involved in neuronal G protein signaling (40) . Inhibition of G z GAP activity by synapsin may provide feedback information to cell surface signaling systems 2 S. A. Barker, personal communication.
of the G z GAP activity of RGS4. The final synapsin concentration in assays was 25 nM. Data are means from three experiments, each with duplicate determinations. Identical parallel experiments were performed using [␥- 32 P]ATP to quantitate phosphorylation under the conditions used. Fractional phosphorylation (moles of P i /mol of protein), determined by scintillation counting of bands cut from the gels, was 0.80 for PAK1 and 0.77 for PKA. After treatment with phosphatase, fractional phosphorylation decreased to 0.14 for PAK1 and 0.08 for PKA. Labeling data are averages from two experiments.
FIG. 10. Phosphorylation of synapsin at Ser
9 by PAK1 and PKA attenuates its GAP-inhibitory activity. A, upper panel, recombinant rat synapsin Ia (1.6 M, OE, ) or synapsin Ia purified from bovine brain (1.6 M, ⅷ, f) was incubated either with partially purified GST-PAK1 (232-544) (100 nM) and 0.5 mM ATP for 3 h at 30°C as described under "Experimental Procedures" or under identical conditions but without PAK. Inhibition of RGS4 GAP activity by phosphorylated (f, ) and control synapsins (ⅷ, OE) was measured as described under "Experimental Procedures." Data points are means from two (natural synapsin) or three (recombinant) experiments, each with duplicate determinations. Below, synapsins were incubated with GST-PAK1-(232-544) and 0.5 mM [␥-32 P]ATP (176 cpm/pmol) for 3 h at 30°C. Samples (4 pmol) were analyzed by SDS-polyacrylamide gel electrophoresis, Coomassie Blue staining (CB), and autoradiography ( 32 P). Purified recombinant G␣ z (4 pmol) was used as a reference substrate in the labeling experiments. Fractional phosphorylation (moles of P i /mol of protein), determined by scintillation counting of bands cut from the gels, was as follows: recombinant synapsin Ia, 0.70; brain synapsin Ia, 0.85; and G␣ z , 0.95. Fractional phosphorylation data are means from four experiments for synapsin and two for G␣ z , with S.D. values of about 10% of the mean. B, recombinant synapsin (0.7 M) was incubated either with PKA catalytic subunit (6 units in 30 l) or partially purified GST-PAK1-(232-544) (150 nM) and 0.33 mM ATP for 2 h at 30°C as described under "Experimental Procedures." Hexokinase (1 unit) and 1 mM glucose were added for another 20 min to remove ATP, and pH was adjusted to 5.5 with 50 mM MES. Each sample was then divided into two aliquots and incubated with or without acid phosphatase ("Ptse") as described under "Experimental Procedures." Aliquots were then assayed for inhibition on the state of the intracellular signaling. Simultaneous regulation of secretion by G z and regulation of G z by synapsin suggest bidirectional information flow in this system. This is similar to the case of communication of the G q family of G proteins with phospholipase C-␤1, which is both the major G q -regulated effector and a G q GAP (41) . Bidirectional communication between G z -coupled receptors on the presynaptic cell membrane and the machinery that organizes synaptic vesicles may thus add a new layer of control to synaptic regulation.
Synapsin is phosphorylated at six previously reported sites by a variety of protein kinases in response to multiple agents. These kinases display overlapping site specificity, and preliminary evidence suggests that seven more serine and threonine residues on synapsin Ia are potential phosphorylation sites in cells. In part because of this complexity, precise functions of synapsin phosphorylation at individual sites and by individual kinases have been hard to specify. Phosphorylation decreases the ability of synapsin to bundle synaptic vesicles on actin filaments in the presynaptic terminal, releases synapsin from vesicles and (apparently thereby) modulates vesicle mobilization and release (16, 25, (42) (43) (44) .
The data shown here indicate that phosphorylation of Ser 9 of synapsin Ia attenuates inhibition of G z GAP activity to a maximum of 80 -90%. PAK, PKA, and CaM kinase II are all known to phosphorylate synapsin Ia at Ser 9 in cells, each in response to a different group of receptors (23, 24) . Control of G z GAP inhibition thus represents a novel regulatory output of synapsin phosphorylation, and modulation of G z GAP activity will reflect inputs through any of these three protein kinases. Initiating signals thus include the tyrosine protein kinase receptors that cause activation of rac or cdc42, which directly activates PAKs (45); the G s -coupled receptors that elevate intracellular cyclic AMP; or the diverse receptors that elevate intracellular Ca 2ϩ . All of these are operative in presynaptic neurons. Our finding that only a small fraction of total brain synapsin Ia is a potent G z GAP inhibitor argues that a significant fraction of synapsin Ia in bovine brain is naturally phosphorylated at Ser 9 . The fraction of synapsin Ia that can regulate G z GAP activity is thus tightly controlled by its phosphorylation-dephosphorylation cycle.
In addition to phosphorylating synapsin, PAK also phosphorylates G␣ z itself at a site near its N terminus and thereby decreases its affinity for both G␤␥ and RGS proteins. PAK can thus both potentiate G␤␥ signaling via G z and protect G z from GAP activity (26) . Both effects potentiate G z -mediated signaling. Multiple regulatory inputs thus allow G z to respond directly to signals from the receptors to which it is coupled, to alter its activity via its own phosphorylation and to respond to synapsin-mediated feedback from the synapse's secretory machinery.
The precise role of G z in modulating neurosecretion is still relatively unclear. Regulation of G z GAP activity by synapsin may represent feedback from the synaptic machinery to enhance G z -mediated signaling. Control by synapsin phosphorylation might involve a potentiative feed-forward effect originating from G z -mediated inhibition of adenylyl cyclase (7) and causing decreased PKA activity. Alternatively, modulation of G z GAP inhibition by PAK or CaM kinase II might indicate off-pathway control of G z function. Last, and most provocative, inhibition of G z GAP activity by synapsin may predominantly mirror the release of synapsin from synaptic vesicles (43) and thus provide inhibitory feedback directly from the synaptic machinery to a secretion-promoting signaling pathway on the presynaptic cell.
